SPOTLIGHT: New HIV drugs lower virus levels


Early-stage clinical trials show that maraviroc, Pfizer's foray into a new class of anti-HIV drugs, significantly decreased levels of the virus in asymptomatic HIV-positive patients, according to data presented today at the 3rd International AIDS Society Conference. Release